Daily Archives: 2012/04/27

IRIDEX launches non-invasive MicroPulse Laser Trabeculoplasty for glaucoma

2012/04/27
By
IRIDEX Corporation today announced the launch of a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse technology. The new glaucoma therapy, a tissue-sparing, repeatable therapy called MicroPulse Laser Trabeculoplasty (MLT), was introduced by IRIDEX at the recent American Society of Cataract and Refractive Surgery (ASCRS).

Full Story →

Macular Degeneration Tied to Stroke Risk (CME/CE)

2012/04/27
By
(MedPage Today) -- Patients with age-related macular degeneration appear to be at risk for both ischemic and hemorrhagic stroke, researchers found.

Full Story →

For AMD, Off-Label Avastin Cheaper Than On-Label Lucentis

2012/04/27
By
There is no national Medicare payment amount for Avastin when the drug is used to treat wet AMD in the office setting. However, physicians often use it off-label, in part due to lower cost.
Medscape Medical News

Full Story →

MCW professor receives 2012 Founders Award at AMSSM meeting

2012/04/27
By
Craig Young, MD, was awarded the 2012 Founders Award at the 21th Annual Meeting of the American Medical Society for Sports Medicine, in Atlanta on April 24, 2012. The award is not given annually, but is bestowed when AMSSM leadership determines that someone exemplifies the best that a sports medicine physician can be and do.

Full Story →

Child Abuse: Ophthalmologists Urged To Be Alert For The Signs

2012/04/27
By
It has been estimated that roughly 4% to 6% of child abuse victims present first to an ophthalmologist...

Full Story →

University of Kentucky researchers make major breakthrough in GA

2012/04/27
By
University of Kentucky researchers, led by Dr. Jayakrishna Ambati, have made a major breakthrough in the "dry" form of age-related macular degeneration known as geographic atrophy.

Full Story →

Amniotic membrane transplantation prevents blindness in patients with SJS

2012/04/27
By
Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a Loyola University Medical Center study has found.

Full Story →

Archives